GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alkaloid AD Skopje (XMAE:ALK) » Definitions » EBIT

Alkaloid AD Skopje (XMAE:ALK) EBIT : MKD1,999 Mil (TTM As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Alkaloid AD Skopje EBIT?

Alkaloid AD Skopje's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2024 was MKD396 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2024 was MKD1,999 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Alkaloid AD Skopje's annualized ROC % for the quarter that ended in Dec. 2024 was 12.56%. Alkaloid AD Skopje's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 11.92%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Alkaloid AD Skopje's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 5.00%.


Alkaloid AD Skopje EBIT Historical Data

The historical data trend for Alkaloid AD Skopje's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alkaloid AD Skopje EBIT Chart

Alkaloid AD Skopje Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,346.82 1,479.63 1,670.50 1,826.49 1,998.85

Alkaloid AD Skopje Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 295.12 559.98 402.58 640.29 396.01

Competitive Comparison of Alkaloid AD Skopje's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Alkaloid AD Skopje's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alkaloid AD Skopje's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alkaloid AD Skopje's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Alkaloid AD Skopje's EV-to-EBIT falls into.


;
;

Alkaloid AD Skopje EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MKD1,999 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alkaloid AD Skopje  (XMAE:ALK) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Alkaloid AD Skopje's annualized ROC % for the quarter that ended in Dec. 2024 is calculated as:

ROC % (Q: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2024 ) + Invested Capital (Q: Dec. 2024 ))/ count )
=2730.58 * ( 1 - 20.16% )/( (0 + 17359.896)/ 1 )
=2180.095072/17359.896
=12.56 %

where

Invested Capital(Q: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=21471.232 - 3737.865 - ( 373.471 - max(0, 5965.591 - 10536.699+373.471))
=17359.896

Note: The Operating Income data used here is four times the quarterly (Dec. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Alkaloid AD Skopje's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2024  Q: Dec. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=1584.036/( ( (0 + max(0, 0)) + (8250.537 + max(5034.435, 0)) )/ 1 )
=1584.036/( ( 0 + 13284.972 )/ 1 )
=1584.036/13284.972
=11.92 %

where Working Capital is:

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3415.155 + 6086.226 + 81.240000000002) - (3737.865 + 0 + 810.321)
=5034.435

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Alkaloid AD Skopje's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2024 )
=1998.853/39961.844
=5.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alkaloid AD Skopje EBIT Related Terms

Thank you for viewing the detailed overview of Alkaloid AD Skopje's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Alkaloid AD Skopje Business Description

Traded in Other Exchanges
N/A
Address
Boulevard Aleksandar, Makedonski 12, Skopje, MKD, 1000
Alkaloid AD Skopje is engaged in producing and selling pharmaceutical, chemical and cosmetic products, as well as goods from the herbal origin. Its segments are Pharmaceuticals, Chemicals, Cosmetics and Botanicals.